TRENDING

TECHNOLOGY NEWS FROM AROUND THE WORLD

→
J&J to install first Ottava robot in US hospital
MedTech DiveIN-DEPTH NEWS

J&J to install first Ottava robot in US hospital

<figure><div><img…

· Published: ·MedTech Dive
Reading progress0%

A first commercial hospital is named

On November 19, 2026, Johnson & Johnson named Memorial Hermann–Texas Medical Center in Houston as the first US hospital slated to install its OTTAVA robotic surgical system under an early-access commercial program. MedTech Dive and RobotsBeat reported the agreement independently. The announcement identifies a customer and a planned installation; it does not specify a completion date, price or the number of systems in the initial program. Naming a hospital therefore does not establish that installation is complete or that routine commercial procedures have begun there.

What the FDA decision covers

The US Food and Drug Administration’s July 21, 2026 De Novo order, DEN250068, classifies OTTAVA as a Class II integrated operating-table electromechanical surgical system. The order describes use by trained physicians in an operating room for adult upper-abdominal general laparoscopic procedures specified in the instructions for use. It assists control of endoscopic instruments, visualization and tissue manipulation, and permits surgical staff to reposition the patient by moving the table without undocking. The authorization is not a blanket approval for every operation or permission for unsupervised autonomous surgery.

How the table and arms fit together

According to the manufacturer, four robotic arms are integrated into a standard-sized surgical table. J&J says the arrangement was designed to address operating-room space and workflow constraints. The platform combines surgical instrumentation, software-enabled functions and compatibility with a digital ecosystem. These are descriptions and intended benefits from the company, not independent comparative evidence that every hospital will perform more procedures or reduce operation time. A robot-assisted platform remains a tool used by a trained clinical team; the presence of robotic arms does not remove the surgeon’s role.

From investigation to commercial use

Memorial Hermann was previously a clinical study site in the investigational device exemption program that supported regulatory authorization. The new announcement should therefore not be described as the system’s first experimental appearance in a hospital. The milestone is the naming of that institution as the first early-access commercial customer. J&J says it plans a rollout to selected US customers while evaluating additional indications. Evaluation of a possible future use does not mean the FDA has authorized that use today.

Competition and limits of the evidence

MedTech Dive placed the announcement alongside an FDA expansion for Medtronic’s Hugo system in upper-abdominal general surgery. The two systems have different regulatory histories and must be assessed against their own indications and instructions. Those milestones alone do not demonstrate that either platform delivers better patient outcomes. FDA classification establishes a regulatory pathway for specified use, not a guarantee of fewer complications or benefit for every patient. Clinical decisions depend on the patient’s circumstances and the judgment of the relevant professionals.

What to watch next

The next verifiable commercial milestones are when installation is completed and how the hospital trains and supports its surgical teams. Patient selection, room preparation, equipment availability and maintenance are relevant to adoption. Assessing safety and clinical outcomes requires appropriately designed, sufficiently sized and independently published comparative evidence; a company announcement cannot answer those questions by itself. The FDA order defines the authorized scope, while MedTech Dive and RobotsBeat provide context on the commercial agreement and its unresolved timing.

Photo: Yazılımcının Günlüğü / Unsplash ↗

Sources and verification

Be the first reader ✎ Write a comment

Comments

No reader comments yet. Be the first to share your view.

Write a comment

Your first and last name will appear publicly alongside your comment.

Your comment appears after submission; spam and duplicate submissions are blocked.